Expanding Therapeutic Horizons
A Clinical Introduction to Psychedelic Therapies
Instant Access
Get immediate access to all course materials and begin your journey today.
Enroll in Masterclass - $250Enrollment takes under 2 minutes and you get immediate next-step instructions.
Training Outcomes
What Our Data Shows
We track outcomes across cohorts. Here's what the numbers say about expanding therapeutic horizons.
Methodology
Exit surveys conducted 30 days post-certification. Response rate: 89%. Dropout analysis shows highest attrition occurs during Phase 1 screening module (months 1-3). Post-certification support includes 12 supervised integration calls over 6 months.
Course Overview
Participants gain a clear map of where psychedelic therapy stands today, legally and clinically, without abandoning professional rigor.
What You'll Learn
- Legal, regulatory, and ethical grounding for psychedelic therapies
- Clinical foundations for ketamine, psilocybin, and MDMA-assisted care
- Preparation, screening, and integration principles
- Professional development guidance for responsible growth
Core Focus Areas
The Modern Therapeutic Landscape
Start with legal status, regulatory shifts, and the historical context that shapes current psychedelic practice.
Substance-Specific Clinical Foundations
Review ketamine, psilocybin, and MDMA through mechanisms of action, therapeutic potential, and practical implementation realities.
Structure Over Hype
Emphasis remains on preparation, screening, safety awareness, and integration support rather than intensity-driven narratives.
Professional Development Pathway
Close with expert lectures, curated resources, and practical next steps for continued education within scope.
Course Curriculum
A structured pathway designed to take you from foundational science to advanced facilitation mastery.
Foundational orientation to the field and its current legal and cultural status. Participants gain clarity about where psychedelic therapy stands today legally and culturally.
- Current legal status and regulatory considerations
- Historical use of psychedelics in clinical settings
- The resurgence of psychedelic research
- Ethical implications of practicing in emerging spaces
Your Guides
A blend of clinical precision and experiential wisdom.
Stephan Kerby
The Visionary
Founder of Mindscape Psychedelic Institute. He bridges the gap between the street and the clinic. A master facilitator of 5-MeO-DMT who understands that trauma-informed care is the only care that matters.
Amber Kerby, LMFT
The Integrator
She blends the clinical world of Marriage and Family Therapy with the depth of Internal Family Systems (IFS) and Ketamine. She knows how to hold space for the parts of us that are most afraid.
Dr. Stephen Mandler
The Psychiatrist
Chief Medical Officer. Board-certified. He has worked from Afghanistan to the Menninger Clinic and brings medical credibility necessary to legitimize this work in clinical settings.
Dr. Desmond Wallington
The Activist-Healer
A licensed psychologist with Indigenous heritage who helped decriminalize nature in DC and Denver. He reminds us that this medicine is old, even when the frameworks are new.